Cargando…
TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination
Adenovirus has enormous potential as a gene-therapy vector, but preexisting immunity limits its widespread application. What is responsible for this immune block is unclear because antibodies potently inhibit transgene expression without impeding gene transfer into target cells. Here we show that an...
Autores principales: | Bottermann, Maria, Foss, Stian, van Tienen, Laurens M., Vaysburd, Marina, Cruickshank, James, O’Connell, Kevin, Clark, Jessica, Mayes, Keith, Higginson, Katie, Hirst, Jack C., McAdam, Martin B., Slodkowicz, Greg, Hutchinson, Edward, Kozik, Patrycja, Andersen, Jan Terje, James, Leo C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187179/ https://www.ncbi.nlm.nih.gov/pubmed/30209217 http://dx.doi.org/10.1073/pnas.1806314115 |
Ejemplares similares
-
Complement C4 Prevents Viral Infection through Capsid Inactivation
por: Bottermann, Maria, et al.
Publicado: (2019) -
TRIM21—From Intracellular Immunity to Therapy
por: Foss, Stian, et al.
Publicado: (2019) -
Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity
por: Caddy, Sarah L, et al.
Publicado: (2020) -
Intracellular neutralisation of rotavirus by VP6-specific IgG
por: Caddy, Sarah L., et al.
Publicado: (2020) -
Antibody and DNA sensing pathways converge to activate the inflammasome during primary human macrophage infection
por: Labzin, Larisa I, et al.
Publicado: (2019)